NCT01924299View on ClinicalTrials.gov

A Study of Baricitinib When Administered With Ketoconazole or Fluconazole in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Healthy Volunteers
Interventions
DRUG

Baricitinib

Administered orally

DRUG

Ketoconazole

Administered orally

DRUG

Fluconazole

Administered orally

Trial Locations (1)

LS2 9LH

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Leeds

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01924299 - A Study of Baricitinib When Administered With Ketoconazole or Fluconazole in Healthy Participants | Biotech Hunter | Biotech Hunter